Johnson & Johnson talc settlement reduces litigation overhang
A proposed $5.5 billion agreement to settle remaining talc-related ovarian cancer lawsuits aims to clear a major long-standing legal liability for Johnson & Johnson.
Keep reading this one
You've read the thesis and who argued it. A free account opens the argument, what validates it, the risks the show raised, and the moment in the episode where it was said — 3 ideas in full a day, no card.